Events
Featured Events
As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable reduced cost of goods and greater access for patients.
As the must-attend meeting for the allogeneic community, the 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.
Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targetin…
The 2nd ESG in Life Sciences Summit Europe is designed to bring together senior leaders in ESG, Sustainability, Compliance, Supply Chain, and Finance, providing actionable insights into the CSRD, CSDDD, and European Reporting Requirements, while tackling single-use plastic, equitable access to medicine, Scope 3 transparency, and more—ultimately empowering companies to build a market-leading ESG framework for long-term success.
Join us in driving the future of Life Sciences sustainability – turning ambition into action, compliance into opportunity, and responsibility into lasting impact for people and the planet.
Events
With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-amplifying RNAs to provide improved stability, durability, longevity and efficacy for treating a wide array of diseases.
This May, the 4th Circular and Self-Amplifying RNA Therapeutics Summit (previously known as 'Next Generation RNA Therapeutics Summit) is landing back in Boston, as the unique opportunity to unite with leading stakeholders in the next generation RNA field, including the likes of Sail Biomedicines, Merck, Novo Nordisk, Replicate Bioscience and more. This is your one-stop shop to hear the latest approaches and applications of circular and self-amplifying RNA therapeutics and vaccine…
Welcome to the 5th Edition of the Chemistry World Conference (Chemistry 2025), set in the historic city of Rome, Italy, from June 2-4, 2025. This hybrid event, themed "Chemistry: Innovations, Applications, and Sustainability," offers both onsite and virtual participation.Chemistry Conferences 2025 unites researchers, academics, industry experts, and enthusiasts globally. Attendees will delve into topics such as analytical chemistry, medicinal chemistry, nanoscience, and structural chemistry. The Medicinal Chemistry Conferences 2025 encourages interdisciplinary learning with discussions on catalysis, biochemistry, and environmental sustainability.Engage in presentations, workshops, and panel discussions on computer-aided drug design, advancements in organic synthesis, and chemistry's impact…
Welcome to the 4th In Vivo Cell Engineering and Gene Editing Summit, the premier event dedicated to enhancing the next frontier of in vivo cell and gene approaches from research to clinic. This summit provides you with exclusive insights into the latest IND enabling data, regulatory and inter-governmental processes and requirements, best-in-class delivery technologies, cutting-edge innovations in editing and engineering and insights into effective clinical trial design from industry leaders including Capstan Therapeutics, Editas Medicine, Carisma Therapeutics, AbbVie, Intellia Therapeutics, Umoja Biopharma and many more!
The in vivo approach is revolutionizing the cell and gene space. These ground-breaking technologies promise more efficient, accessible and cost-effective therapies and pav…
With tightening budgets and increasing pressure to de-risk R AND D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling technologies-from computational modeling and AI-driven predictions to structural biology techniques like Cryo-EM, NMR, and X-ray crystallography-to improve rational drug design and enhance decision-making early in discovery.
While AI-powered structure prediction is transforming the landscape-recognized by the 2024 Nobel Prize for Google DeepMind’s AlphaFold2- its true impact depends on experimental validation. The ability to integrate computational insights with high-resolution structural data is now essential for unlocking complex targets and accelerating drug discovery.
Cryo-EM continues to pus…
05-Jun-2025 - 07-Jun-2025
The 11th Edition of the International Conference on Neurology and Neurological Disorders (Neurology 2025) is set to take place from June 5-7, 2025, in the captivating city of Rome, Italy. This hybrid event, hosted by Magnus Group, provides an exceptional opportunity for both on-site and virtual participation, catering to professionals across the globe.
With the theme "Frontiers of Neurology: Bridging Science, Medicine, and Technology," Neurology Conferences will explore the latest advancements and future directions in neurology. The conference aims to unite experts, researchers, and practitioners to discuss breakthroughs in neurological science, innovative medical treatments, and technological integrations in patient care. Attendees will benefit from a diverse range of sessions, including…
The 3rd International Alzheimer's Disease & Dementia Conference (Dementia 2025) will be held from June 5-7, 2025, in the historic city of Rome, Italy. Under the theme "Beyond Boundaries: Global Advances in Alzheimer's and Dementia Care," this conference will explore cutting-edge research and innovative approaches in the field of dementia care.
Alzheimer's Disease Conferences 2025 offers a hybrid format, combining onsite and online participation to accommodate a global audience. This inclusive setup ensures that experts and participants from around the world can engage in meaningful discussions, share groundbreaking research, and collaborate on advancing dementia care.
Join Dementia Conferences 2025 in Rome for this pivotal event to gain invaluable insights, connect with leading profess…
As regulators and payers increasingly elevate the importance of RWE in submission requirements and with an explosion of datasets opening up in parallel with advancing AI, deep learning, and large language models transforming big data analysis, it has never been more critical to keep up with the matrix of country-specific regulatory nuances and industry case studies in optimizing integrated evidence plans, bullet-proofing data quality, and navigating vendor selection.
The 2nd IMPACCT Real World Evidence Summit Europe is the only industry meeting dedicated to uniting experts in RWE and Evidence Generation to consolidate, innovate and apply RWE across the drug development lifecycle, from external control arms to reimbursement.
With a tight focus on leveraging AI for both efficiency gains and…
Introducing the Vendor Management and Outsourcing for Clinical Trials Summit, built with the industry to the needs of vendor management, outsourcing and clinical operations professionals.
Vendor management processes are crucial for ensuring compliance, quality, and timely delivery at every stage, serving as the backbone of successful clinical trials. Acknowledging the transformative impact, the industry is prioritizing the optimization of these intricate processes, making significant investments to enhance key functions, improve performance, and maintain a competitive edge. Despite this professionals managing ancillary lab vendors and CROs lack a dedicated forum to address their unique challenges, until now...
Join us and uncover exclusive strategies to enhance onboarding and standardizati…
As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable reduced cost of goods and greater access for patients.
As the must-attend meeting for the allogeneic community, the 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.
Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targetin…
The Cardio-Renal-Metabolic (CVRM) Innovation Pharma Partnering Summit is a hyper-aligned business development forum for companies addressing pathologies driving cardiovascular, kidney, and metabolic diseases.
This exclusive summit brings together over 80 on-scope and in-strategy companies, providing targeted face-to-face networking, and opportunities to validate biotech innovations against the interests of pharma and qualified investors.
Designed to maximize your success, the scientifically focused environment of the summit guarantees a minimum of 25% meeting acceptance rates and at least four productive meetings with strong follow-up potential. Increase your meeting success rates and build meaningful collaborations in this exclusive setting.
"The opportunity had gone cold since the initia…
The Pharma Market Research Conference West (June 11-12, 2025, South San Francisco) is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.
The event is unlike any other conference in the Bay Area. It’s immersive, interactive and focused on giving you and your colleagues the methodologies to deal with the new challenges and opportunities facing the industry.
The Pharma Market Research Conference is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years.
For more information, please go to…
16th Annual Clinical Trials Summit 2025
“Mastering Clinical Trials: A Comprehensive Guide to Success”
11th & 12th June 2025, Kohinoor Mumbai - India
16th Annual Clinical Trials Summit 2025 will provide a platform to discuss on the futuristic advancements in Clinical Trials and clinical research. This multidisciplinary program involves broad participation of people from Clinical Trials community who are focused on learning more about clinical research, Clinical Trials planning & management. This event opens discussion of timely topics of mutual theoretical and practical interest for clinical trial investigators who are developing new drugs and biologics.
Please contact Email - kavitha@virtueinsight.co.in or Call - M: +91 9361957193
We have more opportunities for Exhibiti…
The marcus evans 17th Edition Strategic Alliance Management for Pharma conference taking place on 12-13 June, 2025, in Boston, MA, will bring together industry leaders and innovators to explore actionable strategies for licensing, conflict resolution, cultural integration, digital transformation, and navigating cross-border collaborations. Whether you're driving growth through strategic alliances, managing M&A partnerships, or leading global teams, this event delivers cutting-edge insights to elevate your alliances and maximize impact.
Key Topics include:
Generate Win-Win Opportunities and Maximise the Partnership Value
Alliance Leadership and Stakeholder Management - or why “Influence is your Superpower”
What are the strategic ‘value buckets’ of an alliance manager?
Navigate Complexi…
Welcome to the Inaugural Dark Genome Target Discovery and Development Summit
The Dawn of the Dark Genome Has Arrived...
Significant technological advances in computational biology, next-gen sequencing, -omics platforms and AI have unlocked the transformative potential of drug discovery in the dark genome, resulting in investment and partnerships totalling over $1.5 billion in the past 6 months alone.
Designed to bring together the growing community of pioneers, the inaugural Dark Genome Target Discovery and Development Summit is the first industry-focused forum to decipher the mysteries of non-coding DNA and RNA to reveal its role in disease, while uncovering and validating novel targets across oncology, neuroscience, aging, heart disease and beyond!
Featuring a star-studded speaker line-u…
Lipid-based nanoparticles are evolving-faster, safer and more precise than ever. With traditional LNPs struggling to reach tissues beyond the liver, the industry is doubling down on next generation technologies for extra-hepatic. In 2024 alone, Novo Nordisk invested $600M in NanoVation to push genetic medicines further, while Nanite and Saliogen joined forces to pioneer non-viral, lung-targeting nanoparticles.
Formerly known as the Next Gen Lipid-Based Nanoparticle Delivery Summit, the summit is the only industry-dedicated event laser-focused on extrahepatic targeting, delivery efficiency and scalable manufacturing for mRNA, siRNA, DNA and gene therapies.
Join 80+ delivery experts, CXOs and leading scientists from AstraZeneca, Novo Nordisk, Takeda, Orbital Therapeutics and more for three j…
Peptide bioavailability has been significantly enhanced in recent years, evidenced by Pfizer developing an optimized formulation for its oral GLP-1 drug danuglipron, AbbVie buying out Nimble Therapeutics for its oral peptide assets and J and J advancing development of its IL-23 receptor antagonist peptide to address the high unmet need for a durable oral option. Additionally, innovative excipient and delivery approaches are making oral administration of peptides a clinical reality, but bottlenecks remain.
Returning to Boston as your premier industry-dedicated forum, the 2nd Peptide Formulation and Delivery Innovation Summit addresses how to overcome unique formulation challenges and accelerate innovative delivery technology applications to progress peptide-based therapeutic pipelines towar…
The T-cell engager (TCE) field has seen unprecedented growth, with eight approvals in the past two years—most recently tarlatamab—reinforcing its potential as a dominant force in immuno-oncology. Expanding applications in autoimmune diseases and a surge in business development, including Merck and Co.’s acquisition of Harpoon Therapeutics and GSK’s $550M agreement with Chimagen, highlight the industry’s commitment to advancing this modality.
The 7th T-Cell Engager Therapeutics Summit remains the only event exclusively focused on translating TCEs and immune cell engagers from discovery to the clinic and regulatory approval. This year’s program will showcase innovations to improve efficacy and safety in solid tumors while exploring new opportunities in autoimmune indications.
Despite recent…
The 2nd ESG in Life Sciences Summit Europe is designed to bring together senior leaders in ESG, Sustainability, Compliance, Supply Chain, and Finance, providing actionable insights into the CSRD, CSDDD, and European Reporting Requirements, while tackling single-use plastic, equitable access to medicine, Scope 3 transparency, and more—ultimately empowering companies to build a market-leading ESG framework for long-term success.
Join us in driving the future of Life Sciences sustainability – turning ambition into action, compliance into opportunity, and responsibility into lasting impact for people and the planet.
Returning for the 2nd year, the Computational RNA Design and Delivery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs, established large pharma, and key academic opinion leaders committed to training and validating machine learning and artificial intelligence algorithms to accelerate RNA design and delivery with improved efficacy, translation efficiency and specificity.
Following Nobel Prize recognition in 2024, and huge collaborations such as that between Moderna and OpenAI as well as Gensaic and Novo Nordisk, computational approaches such as artificial intelligence and machine continue to dominate large investments and partnerships within the RNA community - highlighting their promise for driving more therapeutically releva…
The 3rd Obesity and Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling the obesity epidemic. This year, we're evaluating the obesity landscape, diving deep into the game-changing potential of novel targets and the latest GLP combination therapies to manage side effects and personalise patient treatment.
Hear from the titans of the pharmaceutical industry - Eli Lilly, Novo Nordisk, Boehringer Ingelheim as well as innovative biotechs including, Altimmune, High Tide Therapeutics, and iBio, and many more - as they share their groundbreaking research and strategies for developing more effective, tolerable, and long-lasting weight management solutions.
Obesity rates are increasing, and the pressure is on for real change. Don't miss this pi…
